1 Introduction Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains one of the most persistent infectious diseases worldwide, posing a major threat to global health despite decades of medical advances [1]. The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains has further complicated disease management, highlighting the limitations of conventional antibiotic therapies [2].